240 related articles for article (PubMed ID: 21088218)
1. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease.
Ongali B; Nicolakakis N; Lecrux C; Aboulkassim T; Rosa-Neto P; Papadopoulos P; Tong XK; Hamel E
Am J Pathol; 2010 Dec; 177(6):3071-80. PubMed ID: 21088218
[TBL] [Abstract][Full Text] [Related]
2. Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice.
Papadopoulos P; Tong XK; Hamel E
Neurobiol Aging; 2014 Jan; 35(1):203-12. PubMed ID: 23954171
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology.
Papadopoulos P; Rosa-Neto P; Rochford J; Hamel E
PLoS One; 2013; 8(7):e68612. PubMed ID: 23874687
[TBL] [Abstract][Full Text] [Related]
4. Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone.
Nicolakakis N; Aboulkassim T; Aliaga A; Tong XK; Rosa-Neto P; Hamel E
J Cereb Blood Flow Metab; 2011 Jan; 31(1):200-11. PubMed ID: 20571524
[TBL] [Abstract][Full Text] [Related]
5. Selective in vivo antagonism of endothelin receptors in transforming growth factor-beta1 transgenic mice that mimic the vascular pathology of Alzheimer's disease.
Papadopoulos P; Ongali B; Hamel E
Can J Physiol Pharmacol; 2010 Jun; 88(6):652-60. PubMed ID: 20628431
[TBL] [Abstract][Full Text] [Related]
6. Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1.
Papadopoulos P; Tong XK; Imboden H; Hamel E
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1959-1970. PubMed ID: 27389178
[TBL] [Abstract][Full Text] [Related]
7. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist.
Nicolakakis N; Aboulkassim T; Ongali B; Lecrux C; Fernandes P; Rosa-Neto P; Tong XK; Hamel E
J Neurosci; 2008 Sep; 28(37):9287-96. PubMed ID: 18784309
[TBL] [Abstract][Full Text] [Related]
8. Cerebral circulation: function and dysfunction in Alzheimer's disease.
Hamel E
J Cardiovasc Pharmacol; 2015 Apr; 65(4):317-24. PubMed ID: 25384195
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Papadopoulos P; Rosa-Neto P; Lecrux C; Imboden H; Hamel E
Neurobiol Dis; 2014 Aug; 68():126-36. PubMed ID: 24807206
[TBL] [Abstract][Full Text] [Related]
10. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.
Lacoste B; Tong XK; Lahjouji K; Couture R; Hamel E
J Neuroinflammation; 2013 May; 10():57. PubMed ID: 23642031
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.
Royea J; Zhang L; Tong XK; Hamel E
J Neurosci; 2017 May; 37(22):5562-5573. PubMed ID: 28476949
[TBL] [Abstract][Full Text] [Related]
13. Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer's disease.
Zhang L; Papadopoulos P; Hamel E
Br J Pharmacol; 2013 Oct; 170(3):661-70. PubMed ID: 23889563
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice.
Buckwalter M; Pepper JP; Gaertner RF; Von Euw D; Lacombe P; Wyss-Coray T
Ann N Y Acad Sci; 2002 Nov; 977():87-95. PubMed ID: 12480736
[TBL] [Abstract][Full Text] [Related]
15. Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling.
Lourenço CF; Ledo A; Barbosa RM; Laranjinha J
Exp Neurol; 2017 May; 291():36-43. PubMed ID: 28161255
[TBL] [Abstract][Full Text] [Related]
16. Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Imboden H; Hamel E
J Alzheimers Dis; 2016; 51(4):1183-95. PubMed ID: 26923013
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Naert G; Rivest S
Mol Med; 2012 Mar; 18(1):297-313. PubMed ID: 22160221
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 factor in the cerebrovascular diseases of Alzheimer's disease.
Zhang X; Huang WJ; Chen WW
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5178-5185. PubMed ID: 28051272
[TBL] [Abstract][Full Text] [Related]
19. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
20. Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease.
Tong XK; Nicolakakis N; Kocharyan A; Hamel E
J Neurosci; 2005 Nov; 25(48):11165-74. PubMed ID: 16319316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
